Healthy
Conditions
Keywords
Intestinal Microbiota, Probiotics, Seaweed, Healthy Subject
Brief summary
The aims of this study are to investigate the effect of seaweeds which is one of the main ingredients of Korean traditional food 'Kimchi' and probiotics on intestinal function of healthy subjects.
Detailed description
Kimchi is one of the the typical and main foods in Korea. Seaweed is one of the important ingredient of Kimchi and has been known to have antiinflammatory, anticoagulant and antiadhesive effects. As seaweeds are fermented in order to make Kimchi, it can encourage beneficial probiotics to grow and lead to preventing digestive problems such as constipation and diarrhea. In this trial, we are going to investigate the effect of combination of seaweeds and probiotics on intestinal function of healthy subject by evaluating intestinal microbiota. The trial is a randomized, double-blinded, placebo-controlled, 2-arm study. Forty patients with normal intestinal condition will be randomly assigned to one of the 2 groups consisting of Seaweed with real probiotics or Seaweed with placebo probiotics. The assigned treatments will last for 4 weeks and the follow-up period will be 2 weeks. Four weeks of administration of seaweeds and probiotics is expected to increase the amount of beneficial microbiota and reduce that of harmful microbiota in intestine. we will also use questionnaires such as K-GSRS (Korean Gastrointestinal symptom rating scale), WHOQOL (The World Health Organization Quality of Life) - BREF and Assessment of bowel function scores (frequency, consistency, ease of passage - based on Bristol stool scale) to assess the change of digestive symptoms and the quality of life.
Interventions
DIETARY_SUPPLEMENTSeaweed and Duolac7S
Seaweed and probiotics is composed of seaweed and Duolac7S. Seaweed: 1. Form: brown granule 2. Dosage and frequency: 1 pack (3 g), 2 packs per day (30 min after morning, and evening meal) 3. Duration: 4 weeks of treatment period Duolac7S: 1. The probiotics, Duolac7S, consist of 7 bacteria. 2. Ingredients: Lactobacillus acidophilus, L. plantarum, L. rhamnosus, Bifidobacterium breve, B. lactis, B. longum, Streptococcus thermophilus. 3. Dosage and frequency: 1 capsule (5✕1,000,000,000 bacteria/capsule \[7✕100,000,000 viable cells/strain\]), 2 capsules per day (30 min after morning and evening meal) 4. Duration: 4 weeks of treatment period
DIETARY_SUPPLEMENTSeaweed and Duolac7S-P
Seaweed and probiotics is composed of seaweed and Duolac7S-P(Placebo Duolac7S). Seaweed: 1. Form: brown granule 2. Dosage and frequency: 1 pack (3 g), 2 packs per day (30 min after morning, and evening meal) 3. Duration: 4 weeks of treatment period Duolac7S-P: Duolac7S placebo has the same form, color and flavor as experimental intervention (Duolac7S). The dosage, frequency and duration is also the same as experimental intervention (Duolac7S).
Sponsors
Korea Institute of Planning & Evalution for Technology of Food, Agriculture, Forestry & Fisherie
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
1. Age of 18 - 75, with a elementary-school diploma or higher, must be literate 2. One who does not have any diseases or clinical symptoms related to digestive system 3. One whose every question of KGSRS is under 3 points 4. One who agree on not taking other therapies during the trial 5. During the past 5 yrs, no history of organic lesion proven by colonoscopy 6. One who agree on consent form
Exclusion criteria
1. Patients who have abdominal operation in the past (exception: appendectomy, caesarean section, tubal ligation, laparoscopic cholecystectomy, hysterectomy and abdominal wall hernia repair) 2. Patients who have history of serious diseases (cholangitis, pancreatitis, enteritis, ulcer, bleeding, cancer, etc.) 3. Before participating clinical trial, one who took over-the-count medication affecting GI motility 4. One who took antibiotics, herbal medicine or probiotics within 2 wks before participating the trial 5. Pregnant woman 6. One who disagree on the consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of intestinal microflora (7 strains of Lactic acid bacteria) | Visit 1(0week), Visit 2(4week) | 1. To investigate the changes of intestinal microbes before and after experiment, feces should be collected. 2. The feces will be analyzed by the method of DGGE (denaturing gradient gel electrophoresis - PCR of DNA). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Daily assessment of bowel function scores | Visit 1(0week), Visit 2(4week), Visit 3(6week) | 1. The patients should write diaries of stool's frequency, consistency and ease of passage 2. Frequency (number of defecation in a day) 3. Consistency (judged by Bristol scale) 4. Ease of passage |
| KGSRS (Korean gastrointestinal symptom rating scale) | Visit 1(0week), Visit 2(4week), Visit 3(6week) | GSRS(Gastrointestinal symptom rating scale) is composed of 15 questions associated with various digestive problems such as abdominal pain, gastrointestinal reflux, indigestion, diarrhea and constipation. KGSRS, the Korean version of GSRS, reflects the language and sociocultural environment of Korea. The reliability and validity was confirm by Gwan et al.,2008. |
| WHOQOL (The World Health Organization Quality of Life) - BREF | Visit 1(0week), Visit 2(4week), Visit 3(6week) | WHOQOL - BREF consists of 4 categories and 26 questions assessing various types of quality of life such as physical, psychological, social relationships and environment function. |
Countries
South Korea
Outcome results
None listed